
In one of the largest venture capital rounds in the state so far this year, Bothell’s Alder BioPharmaceuticals has raised $38 million to support ongoing research for its cancer and migraine headache treatments. Investors in the deal include Novo Ventures, Sevin Rosen Funds, Ventures West, WRF Capital, H.I.G. Ventures, Delphi Ventures and TPG Biotech. As a result… Read More…



















![Seattle Sketch Comedy Month! [June] @ The Ballard Underground | Seattle | Washington | United States](http://2eq9hztv2wc1k6odx469m9znq0.wpengine.netdna-cdn.com/wp-content/uploads/215910-250-167x300.gif)










Most commented